# Blueprint adoption assessment — EZZ Clinic

**Read-only evidence baseline:** 2026-10-30 merged `main` `406c5dd1fd16dd543f2c0b9a3a601af33ae6568b`, the full Google Doc [The Vibe Coding Blueprint](https://docs.google.com/document/d/14GR5EhXGuyX7xRea52ZP3h5vQEP2Egcwvx_SusGWkCc/edit), active Mission Control scope/acceptance, current repository files, and open PRs/issues. This is a **documentation workflow assessment**, not a complete source-code penetration audit, execution test or product acceptance.

## Decision

Adopt the guide's **context → accepted contract → focused plan → smallest change → test and independent review → update the authoritative document** workflow. Do **not** copy the guide's generic 17 templates into the repo: EZZ has real domain documents, generated API contracts, ADRs, safety tests and founder-approved scope. Duplicating them would create contradictions.

## All 17 subjects, mapped to concrete authority

| Guide topic | Current grounded evidence | Improvement / owner / gate |
| --- | --- | --- |
| PRD | Founder `R76_FEATURE_SCOPE_DECISIONS`, `docs/product/`, clinical requirements | Keep one navigable scope map; `#69` acceptance separate from scope |
| DESIGN_SYSTEM | Design draft `#59`; UX batch and decision ledger | Independent FR/AR/390px review, merge only with founder authorization; GPT UX |
| UX_FLOWS | Role-workspaces proposal and frontend security-state map | Explicit successful/error/blocked/offline/retry flows; UX-12 then UX-13/14 |
| ARCHITECTURE | `docs/architecture/architecture.md`, ADRs, SOLID audit | Preserve modular TS/PostgreSQL; reconcile historical statements |
| DATABASE | Full migration source; `schema.md` is only a historical 0001–0007 catalogue | Keep migrations immutable; regenerate the complete schema from current disposable PG16 before relying on it |
| API | Generated `docs/api/openapi.json`, `endpoints.md`, actual tests | Regenerate, validate consumer contracts; no hand-maintained duplicate |
| SECURITY | `docs/security/security-status.md`, `#71` draft and `#72` | Exact-head independent audit and **real production gates** |
| CODE_STYLE | `docs/engineering/standards.md` | Fix obsolete runtime/CI/branch/reviewer text in this PR |
| TESTING | `docs/testing/`, PG16 source/dist + Playwright Actions | Require exact-head evidence/negative paths; `#69` 61 groups open |
| AGENTS | Root `AGENTS.md` | Route to index and enforce documentation triggers without broad rereads |
| ENVIRONMENT | `backend/.env.example` and dev-environment docs | Production env schema, secure secret lifecycle gated by `#72` |
| DECISIONS | ADRs and founder Sheet decision ledger | Preserve dissent/date/SHA, one decision authority per domain |
| ROADMAP | Mission Control `UX_BATCH_COMMAND`, CODEX lane, PRs | Cross-reference active owner and open issues, don't parallel duplicate |
| ERROR_HANDLING | `api/frontend-security-states.md`, payment recovery | Validate 401/403/404/409/429, pending and unknown outcomes in real browser tests |
| OBSERVABILITY | Existing request/security logs and owner audit | Operational alerts, thresholds, retention and response testing: `#72` |
| DEPLOYMENT | Operational/restore research, fictional preview `#44` | Real HTTPS, security sign-off, release/rollback/smoke/restore gate; not approved |
| CHANGELOG | GitHub PRs, test artifacts and Mission Control | Release summaries once a version is explicitly approved; no fake release entries |


## Second-pass coverage assessment of the **17 blueprint areas**

**Interpretation:** these are documentation *topics*, not 17 mandatory filenames or proof of working features. "Documented for development" means a usable current source exists, **not** that its system was independently accepted. "Partial" means some information exists but the original template's important controls or acceptance evidence remain incomplete. "Production-gated" means design material exists but no verified operational rollout procedure is accepted. Review against each newer PR head as work progresses.

| Topic | Documentation maturity | Specific evidence and next acceptance step |
| --- | --- | --- |
| 01 PRD | **Partial** | Founder-approved 61/43/4 V1/Later/Excluded roadmap, clinical requirements and per-feature acceptance. Consolidate **measurable product outcomes** (e.g. receptionist task completion/click effort, right-patient checks, owner review efficacy) with explicit **proposed targets**, baselines and owners; never invent a achieved metric |
| 02 DESIGN_SYSTEM | **Partial / active UX** | `frontend/src/tokens.css` has a basic palette and font stack; [PR #59](https://github.com/EzzeddineAlimi/ezz-clinic-app/pull/59) has proposed Concept A and a required complete token/component specification. Finalize semantic tokens, reusable interaction states, contrast/focus/zoom, FR/Arabic RTL and 1440/390 evidence via existing UX lane, not a parallel redesign |
| 03 ARCHITECTURE | **Documented for development** | `architecture/architecture.md` + ADRs define modular TS/PG16, security/financial boundaries and failure modes. Distinguish original 2026-10-28 snapshot from code and do not treat production hosting assumptions as approved |
| 04 DATABASE | **Partial (catalogue stale)** | All merged `backend/migrations/` are authority; `database/schema.md` describes only migrations 0001–0007. Regenerate the full schema, constraints and index catalogue **from a current disposable PG16 instance**, check drift and never edit past migrations |
| 05 SECURITY | **Partial / production-gated** | Identity/tenant restrictions and [security status](../security/security-status.md) documented. [PR #71](https://github.com/EzzeddineAlimi/ezz-clinic-app/pull/71) is review-pending incremental hardening; [#72](https://github.com/EzzeddineAlimi/ezz-clinic-app/issues/72) tracks production MFA, ingress, rate controls, key custody, quarantine, monitoring, incident and independent tests |
| 06 CODE_STYLE | **Partial — confirmed missing automated lint** | `engineering/standards.md`, strict TS and architecture tests exist. At snapshot **neither `backend/package.json` nor `frontend/package.json` exposes a `lint` or `format:check` script**. Add minimal agreed scoped lint/formatter and CI enforcement in a **separate reviewed engineering PR** (avoid mass reformatting). Do not claim lint was run until implemented |
| 07 TESTING | **Partial (strong dev suites, unaccepted V1)** | PG16 source/dist, timezone matrix, fictional real-API Playwright and accessibility harness exist, but each of 61 V1 groups remains open in [#69](https://github.com/EzzeddineAlimi/ezz-clinic-app/issues/69). Attach exact-SHA user-journey, failure, mobile/RTL, concurrency and skip evidence; don't equate unit pass with workflow release |
| 08 AGENTS | **Documented for development** | Root `AGENTS.md` now routes to `docs/INDEX.md`, founder/role boundaries, small diffs, evidence-first debugging and independent reviews. Compliance depends on each actual agent PR/report, not just presence of instructions |
| 09 UX_FLOWS | **Partial / active UX** | Design proposal [#59](https://github.com/EzzeddineAlimi/ezz-clinic-app/pull/59), `api/frontend-security-states.md` and existing real-browser tests cover important paths. For each role/task, verify **success, loading, empty, forbidden, network loss, stale write, retry and accessible error recovery** across FR/Arabic, including offline paper fallback |
| 10 API | **Documented for development** | Generated `api/openapi.json`, `api/endpoints.md`, server `AppError` and real-API tests. Regenerate when routes, validation or permission contracts change; verify documented error envelopes and client mappings at exact head |
| 11 ENVIRONMENT | **Partial; production gated** | `backend/.env.example`, `engineering/dev-environment.md`, `frontend/README.md` cover fictional dev. Production environment variable ownership, certificate/secret rotation, encrypted backups, network boundaries and safe migration orchestration stay under [#72](https://github.com/EzzeddineAlimi/ezz-clinic-app/issues/72) pending approved hosting choice |
| 12 DECISIONS | **Documented for development** | `architecture/decisions.md`, `decisions/clinical-authorship.md`, founder scope ledger. Preserve dated alternatives, dissent and historical SHAs; confirm decisions changed in current code instead of silently rewriting them |
| 13 ROADMAP | **Documented for development** | Mission Control `UX_BATCH_COMMAND`, `CODEX_ENGINEERING`, founder V1 scope and active PRs. Keep explicit owner, dependency, status and next evidence, without duplicate sprints or self-authorized merge |
| 14 ERROR_HANDLING | **Partial** | `api/frontend-security-states.md`, payment recovery and stable server error envelope cover sensitive states; verify a complete **real-user failure matrix** for 401/403/404/409/423/429/500, DB down, timeout, pending/unknown money outcome and accessible localized recovery. Do not claim all implemented from the map alone |
| 15 OBSERVABILITY | **Production-gated** | Request IDs, allow-listed logs, audit anchors and health readiness exist in development. **No confirmed production dashboards, actionable alert thresholds, responder, drill or retention/telemetry policy**. Define/execute without leaking PHI under [#72](https://github.com/EzzeddineAlimi/ezz-clinic-app/issues/72) |
| 16 DEPLOYMENT | **Production-gated** | Fictional preview [#44](https://github.com/EzzeddineAlimi/ezz-clinic-app/pull/44), developer setup and restoration research exist; no real deployment decision. Require written release ownership, HTTPS, migration/rollback rehearsal, restore proof, smoke checks, monitoring verification and founder/legal/clinical authorization under [#72](https://github.com/EzzeddineAlimi/ezz-clinic-app/issues/72) |
| 17 CHANGELOG | **Partial / pre-release** | PR history and Mission Control preserve change evidence, but there is **no verified versioned clinical release changelog**. At first authorized release create a concise traceable version summary (features, migration, fixes, breaking changes, review SHAs, rollback); don't invent 1.0.0 now |

**Highest-value newly surfaced process omissions:** automated lint/format checks; **measurable acceptance and usability goals** rather than green-CI counts; final versioned design tokens/component behaviors; complete error/incident recovery drills; release and changelog traceability. These **join existing work** rather than restart it. *No production or clinical/security compliance claims are made.*

## Ranked execution without duplicate ownership

1. **P0 before real clinical operation (OPEN):** do not treat software green as deployment clearance; `#72` HTTPS/HSTS and secure reverse proxy, MFA and owner recovery, brute-force/rate protection, malware scanning/quarantine, encryption/key custody, independent penetration testing, backups and restore drill, alerts and local legal/clinical/fiscal/CNAM approval. `#68` branch required CI enforcement and link-sharing safety.
2. **P1 correctness and clinical workflows (ACTIVE):** GPT UX-12 `#60→#62→#64→#65→#66→#70`; independent Muse and Muse Ons review. Dentist and owner workspaces after. Codex `#67` CNAM paper-first; preserve multiple individually named dentists/receptionists, dentist authorship, no hidden clinical authority for desk.
3. **P1 testable acceptance (OPEN):** `#69` maps all 61 approved groups to current-main actual tests and remaining clinical/privacy/UX gates. No completed-count inflation from historical tests or open PRs.
4. **P1 incremental security hardening (ACTIVE):** `#71` new HTTP, strict date, secret-history tripwire and dependency audit is draft; **not** completed or merged. Independent review and exact-head CI before requesting founder merge approval.
5. **P2 developer ergonomics (THIS DRAFT):** docs index, corrected README/standards/AGENTS, minimal PR template. Avoid extra packages, database changes, unnecessary architecture changes or an invented second project-management system.

## Independent final recheck criteria

- Confirm current `main` and PR-head SHAs before making any adoption-status claim.
- Inspect each drafted file against the original content; no production, permissions, API, financial, clinical, security or database source changes in this PR.
- Verify every linked in-repo document exists on merged main, and mark unmerged references as drafts.
- Verify GitHub main branch protection **details** separately: `protected: true` is not evidence that required checks/admin restrictions are enforced; connector currently cannot read the protection details.
- Verify Mission Control `anyone reader` link access is still an accepted **reviewer-dependency risk**: do not revoke blindly or store real patient/secret data.
- Never represent an implementation proposal as a test execution, merge, deployment, or clinical/legal/production clearance.

## What remains unverified

A production hosting architecture, live security operations, independent physical cash counts, actual payment-provider settlement, live malware scanning and legal/current-CNAM compliance remain unverified. A full independent penetration test has not been executed. This assessment alone authorizes **no** production action.
